Literature DB >> 19317954

The epidemiology and recognition of pain and physical symptoms in depression.

Rakesh Jain1.   

Abstract

Patients with major depressive disorder (MDD) often present with pain or other physical symptoms in addition to psychological symptoms. This finding has been replicated in studies across the globe, even though the prevalence of MDD varies greatly internationally. The greater the number of physical symptoms, the more likely the patient is to have a mood disorder, but the presence of pain or physical symptoms negatively impacts physicians' ability to recognize MDD. To improve the recognition of MDD and ensure that patients receive appropriate treatment, clinicians should perform a differential diagnosis that includes psychiatric disorders when patients present with chronic pain or other somatic symptoms. ©Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19317954     DOI: 10.4088/JCP.8001tx1c.e04

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Multiple-Network Alterations in Major Depressive Disorder With Gastrointestinal Symptoms at Rest Revealed by Global Functional Connectivity Analysis.

Authors:  Meiqi Yan; Xiaoya Fu; Yangpan Ou; Feng Liu; Huabing Li; Wenbin Guo
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

3.  Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats.

Authors:  Franciela P Della; Helena M Abelaira; Gislaine Z Réus; Maria Augusta B dos Santos; Débora B Tomaz; Altamir R Antunes; Giselli Scaini; Meline O S Morais; Emilio L Streck; João Quevedo
Journal:  Metab Brain Dis       Date:  2013-01-18       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.